Orchard Therapeutics and SIRION to enhance gene therapy manufacturing efficiency
Orchard Therapeutics appoints Heads of US and EMEA Region Commercial Operations
GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics
Orchard Therapeutics appoints Dr Malech to Scientific Advisory Board
Orchard extends collaboration with Manchester University
Orchard Therapeutics appoints Mark Rothera as President and CEO
Orchard beings manufacturing services agreement with PCT
Orchard Therapeutics Ltd. announces a manufacturing alliance with PharmaCell B.V.
Stem cell gene therapy for fatal childhood disease ready for human trial
Orchard Therapeutics is established with £21m in funding to develop gene therapies for orphan diseases
